Zenate Prenatal
- Generic Name: vitamins prenatal with zinc
- Brand Name: Zenate Prenatal
Patient Information
Do not remove tablets from original unit-dose, child-resistant packaging until use.
Description
| Vitamins: | |
| A* |
3000 I.U.
|
| D (as cholecalciferol) |
400 I.U.
|
| E (as dl-alpha tocopheryl acetate) |
10 I.U.
|
| C (ascorbic acid) |
70 mg
|
| Folic Acid |
1 mg
|
| B1 (as thiamine mononitrate) |
1.5 mg
|
| B2 (riboflavin) |
1.6 mg
|
| B6 (as pyridoxine hydrochloride) |
2.2 mg
|
| B12 (cyanocobalamin) |
2.2 µg
|
| Niacin (as niacinamide) |
17mg
|
| Minerals: | |
| Calcium (from calcium carbonate) |
200 mg
|
| Iodine (from potassium iodide) |
175 µg
|
| Iron (from ferrous fumarate) |
65 mg
|
| Magnesium (from magnesium oxide) |
100 mg
|
| Zinc (from zinc oxide) |
15 mg
|
Amorphous Precipitated Silica, Aqueous Shellac, Croscarmellose Sodium, Crospovidone, Hydrogenated Soybean Oil, Hydrogenated Castor Oil, Hydroxypropyl Cellulose, Hydroxylpropyl Methylcellulose, Magnesium Stearate, Polyethylene Glycol, Polysorbate 80, Powdered Cellulose, Pregelatinized Starch and Titanium Dioxide.
Indications
As a dietary adjunct in nutritional stress associated with periconception, pregnancy and lactation.
Dosage And Administration
One tablet daily or as directed by physician.
How Supplied
Advanced Formula ZENATE® Tablets are white, film-coated scored, capsule-shaped tablets debossed “SOLVAY” on one side and “1472” on the other and supplied in child-resistant unit dose foil pouches.
Unit dose pack of 30 tablets (1 x 30) NDC 0032-1472-26.
Advanced Formula ZENATE® Tablets are supplied in child-resistant unit dose packaging. Do not repackage.
Store at controlled room temperature: 15°- 30° C (59°- 86° F)
CAUTION: Federal Law prohibits dispensing without prescription.
Side Effects
Allergic sensitization has been reported following both oral and parenteral adiministration of folic acid.
Drug Interactions
No information provided.
WarningS
See BOXED WARNING.
Precautions
Folic acid may obscure pernicious anemia, in that hematologic remission can occur while neurologic manifestations remain progressive.
Overdose
No information provided.
Contraindications
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Clinical Pharmacology
No information provided.